Search results

Found 245 pages
AUTHOR: Katrina Megget

11 Dec 2008:

Germany gives Abstral thumbs up

ProStrakan and Orexo have announced their cancer pain drug Abstral has been approved in Germany. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/germany_gives_abstral_thumbs_up_986191

2 Dec 2009:

TriCor and Adderall lawsuits settled

Teva Pharmaceuticals has reached settlements in two massive lawsuits. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/tricor_and_adderall_lawsuits_settled_984169

6 Jan 2011:

Sanofi-Aventis workers strike

French workers at Sanofi-Aventis walked out yesterday inprotest to the company’s latest job cuts. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/sanofi-aventis_workers_strike_979818

13 Oct 2008:

Vernalis and Servier reach milestone

France’s largest privately-owned pharmaceutical company, Servier, and UK partner Vernalis have announced the achievement of the first milestone in their oncology drug discovery collaboration. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/vernalis_and_servier_reach_milestone_986617

16 Sep 2008:

Bayer takes on German biotech Direvo

Bayer Healthcare has bolstered its biologics drive after acquired German biotech company Direvo Biotech for €210 million. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/bayer_takes_on_german_biotech_direvo_987858

17 Dec 2009:

Cancer code cracked

The move towards personalised medicine has catapulted forward after UK scientists identified all mutations in skin and lung cancer and produced the first complete cancer genomes. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/cancer_code_cracked_984085

21 Nov 2014:

SMARTTECH: Rise of robots in healthcare

The world of robotics has started to change. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/smarttech_rise_of_robots_in_healthcare_1002802

4 Apr 2014:

Genomics offers hope to patients

The era of genomics and the possible $1000 genome offers hope to millions of patients with rare diseases, the director of Genetic Alliance UK says. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/genomics_offers_hope_to_patients_1001772

21 Jan 2011:

Pharma growth expected to slow

The end of the boom years has been signalled for pharma, with an anticipated dip in growth to just 1.3% to 2015, according to research from Datamonitor. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/pharma_growth_expected_to_slow_979734

7 Nov 2008: